Redirect Notice
 The previous page is sending you to https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-awaits-fda-decision-whether-its-next-covid-shot-can-be-offered-us-2024-05-24/.

 If you do not want to visit that page, you can return to the previous page.